EMBL Conference: Cancer Genomics | MedGenome

EMBL Conference: Cancer Genomics

MedGenome Inc. is at the EMBL Conference on Cancer Genomics from 1st to 4th November, 2015

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to professionals working in the field of cancer immunology and immunotherapy. Established in 1984,SITC is a 501(c)(3) not-for-profit organization with a growing constituency of academic, government, industry, clinical and basic scientists, and clinicians from around the world.

Through emphasis on high-caliber scientific meetings, dedication to education and outreach activities, focus on initiatives of major importance in the field, and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups,SITC brings together all aspects of the cancer immunology and immunotherapy community.

Related Articles

Test Menu

Genetic Counselling

Microsites

Collaterals

Contact Us